샘플 요청 목록

 카트 문의
시장보고서
상품코드
1777654

세계의 미주신경 자극 시장

Vagus Nerve Stimulation
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 476 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 미주신경 자극 시장은 2030년까지 8억 5,920만 달러에 이를 전망

2024년에 5억 1,570만 달러로 추정되는 미주신경 자극 세계 시장은 2030년에는 8억 5,920만 달러에 이르고, 분석 기간인 2024-2030년 CAGR은 8.9%를 보일 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 이식형 VNS 기기는 CAGR 7.7%를 나타내고, 분석 기간 종료시에는 5억 4,860만 달러에 이를 것으로 예측됩니다. 체외식 VNS 기기 부문의 성장률은 분석 기간에 CAGR 11.2%로 추정됩니다.

미국 시장은 1억 4,050만 달러, 중국은 CAGR12.0%를 보일 것으로 예측

미국의 미주신경 자극 시장은 2024년에 1억 4,050만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 1억 7,130만 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 12.0%로 추정됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 6.4%와 7.7%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 약 6.9%를 나타낼 전망입니다.

세계의 미주신경 자극 시장 - 주요 동향과 촉진요인 정리

왜 미주신경 자극이 뉴로모듈레이션의 혁신의 최전선에 있는 것일까?

미주신경자극(VNS)은 복잡한 신경학적 및 정신과적 질환의 치료에 희망을 가져다주는 광범위한 신경 조절 분야의 혁신적인 접근법으로 최근 몇 년 동안 중요한 모멘텀을 얻고 있습니다. 처음에는 난치성 간질 치료제로 승인되었지만, 이후 VNS는 치료 저항성 우울증, 편두통, 군발두통, 염증성 질환 및 심장 질환에 적용하는 등 그 치료 범위를 넓혀가고 있습니다. 이러한 임상적 다양성이 증가하는 이유는 미주신경이 자율신경계 전체에 광범위한 생리적 영향을 미치고, VNS가 뇌 회로, 신경전달물질 분비 및 염증 경로를 조절할 수 있기 때문입니다. 최신 VNS 장치에는 이식형과 비침습형 시스템이 있으며, 경피적 VNS(tVNS)는 사용 편의성과 시술 위험 감소로 많은 사랑을 받고 있습니다. 경피적 VNS는 수술용 리드선 또는 귀나 목의 전극을 통해 미주신경에 제어된 전기 자극을 공급합니다. 기존 치료의 대안으로 약물을 사용하지 않는 장기적인 치료법을 찾는 환자가 증가함에 따라, VNS는 특히 만성적이고 치료 저항성이 있는 질환에서 실행 가능한 솔루션으로 부상하고 있습니다. 임상적 근거가 늘어남에 따라 더 많은 의사들이 VNS를 다학제적 치료 모델에 통합하고 있으며, 치료 적응증 확대와 함께 환자들의 관심도 높아지고 있습니다. 이러한 변화는 개인 맞춤형 신경 표적 의료의 한 축으로서 VNS의 중요성이 커지고 있음을 강조하고 있습니다.

기술 혁신은 VNS 장비의 효율성과 접근성을 어떻게 향상시키고 있는가?

기술의 발전은 미주신경 자극 장치의 능력과 도달 범위를 재정의하는 데 결정적인 역할을 하고 있습니다. 최신 세대의 이식형 VNS 시스템은 심박수나 뇌파 데이터와 같은 생리적 맥박을 기반으로 전기 펄스를 실시간으로 적응시키는 반응형 또는 교차 자극을 특징으로 합니다. 이러한 지능형 장치는 환자의 순응도에 중요한 요소인 부작용을 최소화하면서 치료 결과를 개선합니다. 비침습적 대안, 특히 tVNS 웨어러블은 치료 일정의 유연성을 도입하여 수술의 필요성을 줄이고 집에서 치료할 수 있도록 했습니다. 배터리 수명, 디바이스 프로그래밍 가능성, 소형화도 크게 개선되어 사용자의 편안함과 편의성 향상에 기여하고 있습니다. 모바일 애플리케이션과 클라우드 기반의 분석 기능과의 통합을 통해 원격 모니터링, 임상의의 피드백, 개별화된 투약 요법을 가능하게 하고, 지속적인 치료 모델의 문을 열었습니다. 일부 VNS 플랫폼은 환자별 반응에 따라 치료 파라미터를 미세 조정하는 머신러닝 알고리즘을 모색하고 있습니다. 또한, 디지털 정신건강 도구, 수면 모니터링 앱 등 다른 의료 기술과의 상호운용성을 통해 보다 종합적인 환자 지원이 가능해졌습니다. 이러한 기술 혁신으로 VNS는 고도로 전문화된 병원 기반 치료에서 외래 환자 및 원격 의료 환경 모두에서 관련성이 높아지는 보다 광범위하고 적응력이 높은 솔루션으로 변화하고 있습니다.

시장 성숙에 있어 의약품 승인 및 연구 파이프라인은 어떤 역할을 하는가?

미주신경 자극을 둘러싼 규제 및 임상시험 상황은 빠르게 진화하고 있으며, 신뢰성 향상, 검증 및 상업화 기회를 통해 시장 확대를 촉진하고 있습니다. 미국 FDA와 유럽 CE 마크 당국은 다양한 적응증에 대한 VNS 기기의 승인을 확대하여 기존 의료 기술 기업과 신생 기업의 혁신을 촉진하고 있습니다. 예를 들어, 비침습적 VNS 장치는 두통 장애로 시장 진입을 이루었고, PTSD, 염증성 장질환 등의 증상으로 혁신의료기기 지정을 받았습니다. 이러한 마일스톤은 유효성과 안전성을 입증할 뿐만 아니라, 추가 개발을 위한 가속화된 경로를 지원합니다. 동시에 이명, 섬유근육통, 불안, 류마티스 관절염, 알츠하이머병과 관련된 인지기능 저하와 같은 질병에 VNS를 적용하는 것이 강력한 임상시험 파이프라인에 의해 검토되고 있습니다. 이러한 잠재적 응용 분야 포트폴리오의 확대는 VNS 치료의 적응성을 강조하고, 투자자, 의료진 및 환자에게 VNS의 가치 제안을 강화합니다. 신경조절 연구를 위한 공공-민간 자금도 증가하고 있으며, 바이오 전자 임플란트, 유전자 조절 신경 인터페이스 등 차세대 VNS 도입 메커니즘 탐구를 위한 산학 공동연구에 박차를 가하고 있습니다. 이러한 개발이 진행됨에 따라 얻은 데이터는 임상 가이드라인에서 VNS의 역할을 확고히 하고, 상환 프레임워크의 확장을 촉진하며, 시장 채택을 더욱 촉진할 수 있을 것으로 기대됩니다.

미주신경 자극 솔루션의 세계 수요를 견인하는 요인은 무엇인가?

미주신경 자극 시장의 성장은 기술 발전, 치료의 다양화, 치료 패러다임의 변화, 환자 참여 증가와 직결되는 몇 가지 요인에 의해 주도되고 있습니다. 전 세계적으로 간질이나 우울증과 같은 신경계 질환의 유병률 증가, 특히 고령화 및 치료 저항성 인구 증가로 인해 약리학적 부담 없이 장기적인 완화를 제공하는 대체 요법에 대한 지속적인 수요가 발생하고 있습니다. 비침습적 VNS 장비의 가용성과 수용성이 확대되면서 환자와 의료진의 진입장벽이 낮아져 외래환자 및 재택의료 현장에서의 도입이 가속화되고 있습니다. 생체 전자 의학 및 염증, 스트레스, 기분에서 미주신경의 조절 역할에 대한 인식이 높아지면서 임상과 건강 양면에서 새로운 관심을 받고 있습니다. 의료 시스템과 보험사들은 특히 만성 투약이나 입원 비용이 많이 드는 경우, 비용 효율적인 개입으로 신경 조절에 점차 동조하고 있습니다. 또한, 개인 맞춤형 의료 트렌드와 디지털 헬스 툴의 통합으로 환자는 보다 적극적으로 치료를 관리할 수 있게 되었으며, VNS 플랫폼은 실시간 데이터와 적응 치료를 제공하게 되었습니다. 의료 기술 기업의 빠른 기술 혁신은 유리한 규제 지정 및 신경 기술 연구에 대한 투자 증가와 함께 북미, 유럽 및 아시아태평양과 같이 연구 개발이 빠르게 진행되는 지역으로 시장 실적을 넓히고 있습니다. 이러한 움직임을 종합하면, VNS는 전 세계 치료 상황에서 강력하고 확장 가능한 솔루션으로 자리매김하고 있습니다.

부문

제품(이식형 VNS 장비, 외부 VNS 장비), 생체 재료(금속, 세라믹, 폴리머), 용도(간질, 우울증, 편두통), 최종 용도(병원, 신경과 클리닉, 외래수술센터(ASC), 연구센터)

조사 대상 기업 예

  • BioControl Medical
  • Boston Scientific Corporation
  • Cirtec Medical
  • Cyberonics, Inc.
  • electroCore, Inc.
  • Endonovo Therapeutics, Inc.
  • EnteroMedics Inc.
  • Helius Medical Technologies, Inc.
  • Inspire Medical Systems, Inc.
  • LivaNova PLC
  • Masimo Corporation
  • Medtronic plc
  • MicroTransponder Inc.
  • Nevro Corp.
  • NeuroMetrix, Inc.
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • Parasym Ltd
  • SetPoint Medical Corporation
  • tVNS Health GmbH

AI 통합

우리는 검증 된 전문가 컨텐츠와 AI툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.08.01

Global Vagus Nerve Stimulation Market to Reach US$859.2 Million by 2030

The global market for Vagus Nerve Stimulation estimated at US$515.7 Million in the year 2024, is expected to reach US$859.2 Million by 2030, growing at a CAGR of 8.9% over the analysis period 2024-2030. Implantable VNS Device, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$548.6 Million by the end of the analysis period. Growth in the External VNS Device segment is estimated at 11.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$140.5 Million While China is Forecast to Grow at 12.0% CAGR

The Vagus Nerve Stimulation market in the U.S. is estimated at US$140.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$171.3 Million by the year 2030 trailing a CAGR of 12.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.4% and 7.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.9% CAGR.

Global Vagus Nerve Stimulation Market - Key Trends & Drivers Summarized

Why Is Vagus Nerve Stimulation at the Forefront of Neuromodulation Breakthroughs?

Vagus nerve stimulation (VNS) has gained critical momentum in recent years as a transformative approach within the broader field of neuromodulation, offering hope in the treatment of complex neurological and psychiatric conditions. Originally approved for refractory epilepsy, VNS has since expanded its therapeutic reach to include treatment-resistant depression, migraine, cluster headaches, and even promising applications in inflammatory diseases and cardiac disorders. This growing clinical versatility stems from the vagus nerve’s extensive physiological influence across the autonomic nervous system, enabling VNS to modulate brain circuits, neurotransmitter release, and inflammatory pathways. Modern VNS devices include both implantable and non-invasive systems, with transcutaneous VNS (tVNS) gaining favor for its ease of use and reduced procedural risks. These devices deliver controlled electrical impulses to the vagus nerve, either via surgical leads or external ear or neck-based electrodes. With an increasing number of patients seeking drug-free, long-term alternatives to conventional treatments, VNS has emerged as a viable solution, particularly in chronic and treatment-resistant conditions. As the body of clinical evidence grows, more physicians are integrating VNS into multidisciplinary care models, and patient interest is rising in parallel with expanded therapeutic indications. This shift underscores the growing importance of VNS as a pillar of personalized, neuro-targeted medicine.

How Are Technological Innovations Enhancing the Efficacy and Accessibility of VNS Devices?

Technological advancements are playing a decisive role in redefining the capabilities and reach of vagus nerve stimulation devices. The latest generation of implantable VNS systems now feature responsive or closed-loop stimulation, allowing real-time adaptation of electrical pulses based on physiological markers such as heart rate or electroencephalographic data. These intelligent devices improve therapeutic outcomes while minimizing side effects, a crucial factor in patient adherence. Non-invasive options, particularly tVNS wearables, have introduced flexibility in treatment schedules, reducing the need for surgery and enabling at-home therapy. Battery life, device programmability, and miniaturization have also seen significant improvements, contributing to enhanced comfort and convenience for users. Integration with mobile applications and cloud-based analytics allows remote monitoring, clinician feedback, and individualized dosing regimens, opening doors for continuous care models. Some VNS platforms are exploring machine learning algorithms to fine-tune therapy parameters based on patient-specific responses. Additionally, device interoperability with other health technologies, such as digital mental health tools or sleep monitoring apps, is enabling more holistic patient support. These innovations are transforming VNS from a highly specialized hospital-based therapy into a broader, more adaptable solution with growing relevance in both outpatient and telehealth environments.

What Role Do Regulatory Approvals and Research Pipelines Play in Market Maturation?

The regulatory and clinical trial landscape surrounding vagus nerve stimulation is rapidly evolving, fostering market expansion through increased trust, validation, and commercialization opportunities. The U.S. FDA and European CE Mark authorities have broadened approval for VNS devices across various indications, encouraging innovation among both established medtech companies and start-ups. For instance, non-invasive VNS devices have gained market entry for headache disorders and have received Breakthrough Device Designation for conditions such as PTSD and inflammatory bowel disease. These milestones not only validate efficacy and safety but also support accelerated pathways for further development. Concurrently, a robust pipeline of clinical trials is exploring VNS applications in disorders such as tinnitus, fibromyalgia, anxiety, rheumatoid arthritis, and even cognitive decline linked to Alzheimer's disease. This expanding portfolio of potential uses underscores the adaptability of VNS therapy and enhances its value proposition to investors, healthcare providers, and patients. Public and private funding for neuromodulation research is also growing, fueling academic-industry collaborations aimed at exploring next-gen VNS delivery mechanisms, including bioelectronic implants and gene-modulated neural interfaces. As these developments continue, the resulting data will solidify the role of VNS in clinical guidelines and encourage reimbursement frameworks to widen, further stimulating market adoption.

What Factors Are Driving the Global Demand for Vagus Nerve Stimulation Solutions?

The growth in the vagus nerve stimulation market is driven by several factors directly linked to technological advancements, therapeutic diversification, changing treatment paradigms, and increasing patient engagement. The rising global incidence of neurological disorders such as epilepsy and depression-especially among aging and treatment-resistant populations-is creating sustained demand for alternative therapies that offer long-term relief without pharmacological burden. The expanding availability and acceptance of non-invasive VNS devices have lowered the entry barrier for patients and providers alike, fueling adoption across outpatient and home care settings. Increased awareness of bioelectronic medicine and the vagus nerve’s regulatory role in inflammation, stress, and mood is also attracting new interest from both clinical and wellness perspectives. Healthcare systems and insurers are gradually aligning with neuromodulation as a cost-effective intervention, especially in cases where chronic medication and hospitalization costs are high. Furthermore, personalized medicine trends and the integration of digital health tools are empowering patients to manage their treatment more proactively, with VNS platforms increasingly offering real-time data and adaptive therapy. Rapid innovation from medtech companies, combined with favorable regulatory designations and growing investment in neurotechnology research, is expanding the market footprint across North America, Europe, and rapidly developing regions like Asia-Pacific. Collectively, these dynamics are positioning VNS as a powerful, scalable solution within the global therapeutic landscape.

SCOPE OF STUDY:

The report analyzes the Vagus Nerve Stimulation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Implantable VNS Device, External VNS Device); Biomaterial (Metallic, Ceramics, Polymeric); Application (Epilepsy, Depression, Migraine); End-Use (Hospitals, Neurology Clinics, Ambulatory Surgery Centers, Research Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

  • BioControl Medical
  • Boston Scientific Corporation
  • Cirtec Medical
  • Cyberonics, Inc.
  • electroCore, Inc.
  • Endonovo Therapeutics, Inc.
  • EnteroMedics Inc.
  • Helius Medical Technologies, Inc.
  • Inspire Medical Systems, Inc.
  • LivaNova PLC
  • Masimo Corporation
  • Medtronic plc
  • MicroTransponder Inc.
  • Nevro Corp.
  • NeuroMetrix, Inc.
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • Parasym Ltd
  • SetPoint Medical Corporation
  • tVNS Health GmbH

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Vagus Nerve Stimulation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Neurological and Psychiatric Disorders Drives Demand for Vagus Nerve Stimulation Therapies
    • Expansion of Non-Invasive VNS Devices Spurs Growth in At-Home and Outpatient Treatment Adoption
    • Advancements in Closed-Loop and Responsive Stimulation Technologies Strengthen the Business Case for Smart VNS Systems
    • FDA Approvals and Breakthrough Device Designations Propel Market Expansion Across New Therapeutic Indications
    • Growing Use of VNS in Treatment-Resistant Depression and Epilepsy Sustains Long-Term Market Growth
    • Integration of VNS With Wearables and Mobile Health Apps Generates Opportunities for Remote Monitoring Solutions
    • Increased Focus on Bioelectronic Medicine Throws the Spotlight on VNS as a Pillar of Neuromodulation Therapies
    • Consumer Preference for Drug-Free Chronic Condition Management Drives Adoption of Implant-Free VNS Alternatives
    • Emerging Applications in Cognitive Health and PTSD Generate Demand for Specialized VNS Protocols
    • Increasing Awareness of the Gut-Brain Axis and Autonomic Nervous System Function Enhances Interest in VNS Therapies
    • Global Aging Population and Rise in Neurodegenerative Diseases Create Sustainable Demand for VNS Interventions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Vagus Nerve Stimulation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Vagus Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Implantable VNS Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Implantable VNS Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Implantable VNS Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for External VNS Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for External VNS Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for External VNS Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Neurology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Neurology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Neurology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Metallic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Metallic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Metallic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Ceramics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Ceramics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Ceramics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Polymeric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Polymeric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Polymeric by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Epilepsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Depression by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Migraine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • JAPAN
    • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • CHINA
    • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 77: China Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 86: China Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: China Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: China 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • EUROPE
    • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Vagus Nerve Stimulation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Europe 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • FRANCE
    • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 104: France Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 107: France Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: France Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: France 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 113: France Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: France 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • GERMANY
    • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Germany 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Germany 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Germany 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Italy 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Italy 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Italy 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 140: UK Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: UK 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 143: UK Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: UK 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 149: UK Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: UK 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Spain 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 155: Spain Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Spain Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Spain 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 158: Spain Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Spain Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Spain 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 161: Spain Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Spain Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Spain 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Russia 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 167: Russia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Russia Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Russia 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 170: Russia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Russia Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Russia 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 173: Russia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Russia Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Russia 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Europe 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Europe 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Europe Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Europe 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Europe Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Europe 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Vagus Nerve Stimulation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Asia-Pacific Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Asia-Pacific Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 203: Australia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Australia Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Australia 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 206: Australia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Australia Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Australia 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 209: Australia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Australia Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Australia 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 212: Australia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Australia Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Australia 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • INDIA
    • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 215: India Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: India Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: India 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 218: India Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: India Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: India 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 221: India Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: India Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: India 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 224: India Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: India Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: India 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: South Korea Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: South Korea 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 230: South Korea Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: South Korea Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: South Korea 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 233: South Korea Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: South Korea Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: South Korea 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 236: South Korea Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: South Korea Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: South Korea 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Asia-Pacific Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Asia-Pacific Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Asia-Pacific Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 252: Latin America Historic Review for Vagus Nerve Stimulation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Latin America 15-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Latin America 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Latin America Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Latin America 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 260: Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Latin America Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Latin America 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 263: Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Latin America Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Latin America 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Argentina Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Argentina 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 269: Argentina Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Argentina Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Argentina 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 272: Argentina Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Argentina Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Argentina 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 275: Argentina Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Argentina Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Argentina 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Brazil Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Brazil 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 281: Brazil Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Brazil Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Brazil 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 284: Brazil Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Brazil Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Brazil 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 287: Brazil Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Brazil Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Brazil 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Mexico Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Mexico 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 293: Mexico Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Mexico Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Mexico 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 296: Mexico Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Mexico Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Mexico 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 299: Mexico Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Mexico Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Mexico 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Latin America 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Latin America Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Latin America 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Latin America Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Rest of Latin America 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Rest of Latin America Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 313: Rest of Latin America 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 315: Middle East Historic Review for Vagus Nerve Stimulation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 316: Middle East 15-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 319: Middle East 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Middle East Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 322: Middle East 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 323: Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Middle East Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 325: Middle East 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 326: Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Middle East Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 328: Middle East 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 329: Iran Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Iran Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 331: Iran 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 332: Iran Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Iran Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 334: Iran 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 335: Iran Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Iran Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 337: Iran 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 338: Iran Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Iran Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 340: Iran 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 341: Israel Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Israel Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 343: Israel 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 344: Israel Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Israel Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 346: Israel 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 347: Israel Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Israel Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 349: Israel 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 350: Israel Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Israel Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 352: Israel 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Saudi Arabia Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 355: Saudi Arabia 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Saudi Arabia Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 358: Saudi Arabia 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Saudi Arabia Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 361: Saudi Arabia 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Saudi Arabia Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 364: Saudi Arabia 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 365: UAE Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 366: UAE Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 367: UAE 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 368: UAE Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 369: UAE Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 370: UAE 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 371: UAE Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 372: UAE Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 373: UAE 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 374: UAE Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 375: UAE Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 376: UAE 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Rest of Middle East Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 379: Rest of Middle East 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Middle East Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 382: Rest of Middle East 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Rest of Middle East Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 385: Rest of Middle East 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Rest of Middle East Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 388: Rest of Middle East 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • AFRICA
    • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 389: Africa Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Africa Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 391: Africa 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 392: Africa Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Africa Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 394: Africa 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 395: Africa Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Africa Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 397: Africa 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 398: Africa Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Africa Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 400: Africa 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제